4-(3-吡啶基)-1-丁醛 | 145912-93-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-(3-吡啶基)-1-丁醛
• 英文名称: 4-(3-pyridinyl)butyraldehyde
• 英文别名: 4-(3-pyridyl)butanal；4-(pyridin-3-yl)butyraldehyde；3-Pyridinebutanal；4-pyridin-3-ylbutanal
• CAS: 145912-93-2
• 化学式: C₉H₁₁NO
• 分子量: 149.192
• InChiKey: LGCBVEQNSDSLIH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(3-吡啶基)-1-丁醛 在 sodium tetrahydroborate 、 magnesium sulfate 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 氘代氯仿 、 二氯甲烷 为溶剂， 生成 2-[3-[2-[benzyloxycarbonyl-[4-(pyridin-3-yl)butyl]amino]ethyl]-2-(3,5-dimethylphenyl)-1H-indol-5-yl]-2-methylpropionic acid ethyl ester
  参考文献：
  名称：

  Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus

  摘要：

  A pyridine side-chain terminus has been incorporated into the indole-5-carboxamide and indole-5-acetamide series of GnRH antagonists. Potent activity was observed in binding and functional assays. Certain branched or cyclic tertiary amides were identified as preferred in each series. Alkylation of the side-chain secondary amine had generally unfavorable effects. Variations of the gem-dialkyl substituents in the indole-5-acetamide series were also investigated. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00275-x
• 作为产物：
  描述：

  4-(3-吡啶基)-3-丁炔-1-醇 在 platinum(IV) oxide 草酰氯 、 氢气 、 二甲基亚砜 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 4-(3-吡啶基)-1-丁醛
  参考文献：
  名称：

  Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnRH Receptor Antagonists

  摘要：

  A series of heterocyclic 2-(3,5-dimethylphenyl)tryptamine derivatives was prepared and evaluated on a rat gonadotropin releasing hormone receptor assay. The carbon tether length and heterocyclic ring attached to the amino group of 2-(3,5-dimethylphenyl)tryptamine were varied. Several of these derivatives were potent GnRH antagonists with the most potent compound having an IC50 of 16nM. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00133-0

文献信息

• Total syntheses of macrocyclic marine alkaloids, haliclamines A and B: A convenient and expeditious assembly of 3-substituted pyridine derivatives with different alkyl chains to the bispyridinium macrocycle
  作者：Yoshiki Morimoto、Chiho Yokoe、Hajime Kurihara、Takamasa Kinoshita

  DOI：10.1016/s0040-4020(98)00752-2

  日期：1998.10

  The total syntheses of haliclamines A (1) and B (2), macrocyclic marine alkaloids closely related to the key bisdihydropyridine intermediate 3 of the biogenetically unique manzamine family, have efficiently been achieved via stepwise controlled inter- and intramolecular N-alkylations of 3-alkylpyridine derivatives such as 40 and 41. The general synthetic methodology toward the bispyridinium macrocycle

  通过逐步控制3-的分子间和分子内N-烷基化反应，可以有效地实现与生物素类独特的曼扎明家族的关键双二氢吡啶中间体3密切相关的大环海洋生物碱盐胺A（1）和B（2）的总合成。烷基吡啶衍生物，例如40和41。通过总合成，已经提出了针对双吡啶大环44的通用合成方法，双吡啶大环44是多环海洋生物碱的关键生物遗传等效物。
• N-Heterocyclic Carbene Catalyzed Enantioselective α-Fluorination of Aliphatic Aldehydes and α-Chloro Aldehydes: Synthesis of α-Fluoro Esters, Amides, and Thioesters
  作者：Xiuqin Dong、Wen Yang、Weimin Hu、Jianwei Sun

  DOI：10.1002/anie.201409961

  日期：2014.11.13

  asymmetric fluorination of azolium enolates that are generated from readily available simple aliphatic aldehydes or α‐chloro aldehydes and N‐heterocyclic carbenes (NHCs) is described. The process significantly expands the synthetic utility of NHC‐catalyzed fluorination and provides facile access to a wide range of α‐fluoro esters, amides, and thioesters with excellent enantioselectivity. Pyrazole was identified

  描述了由容易获得的简单脂族醛或α-氯醛与N-杂环卡宾（NHC）生成的烯醇氮的不对称氟化。该工艺极大地扩展了NHC催化氟化的合成效用，并提供了对多种具有出色对映选择性的α-氟代酯，酰胺和硫代酯的简便方法。吡唑被认为是催化酰胺形成的极佳酰基转移试剂。
• <p>Synthesis and antitumor activity of novel pyridinium fullerene derivatives</p>
  作者：Takumi Yasuno、Tomoyuki Ohe、Hitomi Ikeda、Kyoko Takahashi、Shigeo Nakamura、Tadahiko Mashino

  DOI：10.2147/ijn.s212045

  日期：——

  cis-14 (15 mg/kg) significantly exhibited antitumor activity in mouse xenograft model of human lung cancer. CONCLUSION We synthesized a novel set of mono-adduct fullerene derivatives functionalized with pyridinium groups and found that most of them show potent antiproliferative activities against cancer cell lines and some of them show significant antitumor activities in vivo. We propose that these fullerene

  目的我们之前曾报道过一些阳离子富勒烯衍生物具有抗癌活性，预计它们将成为一种潜在的抗癌药物的先导化合物。然而，它们是双加合物和多种区域异构体的混合物，由于富勒烯笼上取代基位置的可变性，它们不容易分离。为了克服这个问题，我们评估了一组单加合物衍生物的抗增殖活性并检查了它们的构效关系。此外，还检查了所选衍生物的体内抗肿瘤活性。方法本研究新设计合成了19种吡啶鎓富勒烯衍生物。使用包括耐药细胞在内的几种癌细胞系评估了它们的抗增殖活性。此外，在人肺癌的小鼠异种移植模型中研究了几种衍生物的体内抗肿瘤活性。结果 衍生物抑制癌细胞系的增殖，包括顺铂耐药细胞和多柔比星耐药细胞。还显示化合物 10 (10 μM)、13 (10 μM) 和 cis-14 (10 μM) 诱导细胞内氧化应激。此外，化合物 13 (20 mg/kg) 和 cis-14 (15 mg/kg) 在人肺癌小鼠异种移植模型中表现出显着的抗肿瘤活性。结论
• 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
  申请人：——

  公开号：US20040002513A1

  公开（公告）日：2004-01-01

  The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C 1-4 alkyl. The substituent at the 3-position of the 1-azabicycloalkane is a carbonyl group-containing moiety, such as an amide, carbamate, urea, thioamide, thiocarbamate, thiourea or similar functionality. The compounds exhibit activity at nicotinic acetylcholine receptors (nAChRs), particularly the &agr;7 nAChR subtype, and are useful towards modulating neurotransmission and the release of ligands involved in neurotransmission. Methods for preventing or treating conditions and disorders, including central nervous system (CNS) disorders, which are characterized by an alteration in normal neurotransmission, are also disclosed. Also disclosed are methods for treating inflammation, autoimmune disorders, pain and excess neovascularization, such as that associated with tumor growth.

  本发明涉及3-取代-2-(芳基烷基)-1-氮杂双环烷类化合物，制备这些化合物的方法以及使用这些化合物进行治疗的方法。这些氮杂双环烷通常是氮杂双环庚烷、氮杂双环辛烷或氮杂双环壬烷。芳基烷基中的芳基是一个5-或6-成员环杂芳基，优选是3-吡啶基和5-嘧啶基，烷基通常是C1-4烷基。1-氮杂双环烷的3-位取代基是一个含有羰基的基团，例如酰胺、碳酸酯、脲、硫代酰胺、硫代碳酸酯、硫脲或类似功能基团。这些化合物在尼古丁型乙酰胆碱受体(nAChRs)上表现出活性，特别是α7 nAChR亚型，并且对调节神经递质传递和与神经递质有关的配体释放具有用处。还公开了用于预防或治疗中枢神经系统（CNS）疾病等疾病和疾病的方法，这些疾病和疾病以正常神经递质传递的改变为特征。还公开了用于治疗炎症、自身免疫疾病、疼痛和过度新生血管化的方法，例如与肿瘤生长相关的新生血管化。
• Antagonists of gonadotropin releasing hormone
  申请人：Merck & Co., Inc.

  公开号：US05780437A1

  公开（公告）日：1998-07-14

  There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

  公开了化合物的化学式(I) ##STR1## 及其药学上可接受的盐，这些化合物可作为GnRH的拮抗剂，因此可能对男性和女性的各种与性激素相关的疾病和其他疾病的治疗有用。